HMGB1: A Novel Player In The Pathogenesis Of Inflammatory Myositis?
Funder
National Health and Medical Research Council
Funding Amount
$84,800.00
Summary
The project aims to determine whether HMGB1, a pro-inflammatory molecule, plays a key role in the cause of inflammatory myositis, an extremely disabling muscle condition characterised by progressive weakness.
Citrullination In Rheumatic And Non-rheumatic Diseases
Funder
National Health and Medical Research Council
Funding Amount
$89,699.00
Summary
Rheumatoid arthritis is a common condition affecting about 1% of the population, leading to damage of joints and subsequently impaired function. This damage is caused by an immune system which rather than defending the host against threats such as infections, inadvertently attacks the host leading to joint damage. Ultimately a better understanding of the abnormal immune responses in patients with RA will allow us to more accurately the diagnose and manage this condition
Improved Tissue Characterisation With Cardiac Magnetic Resonance Imaging And Echocardiography In Identification Of Acute Rheumatic Fever And Its Chronic Sequelae
Funder
National Health and Medical Research Council
Funding Amount
$124,676.00
Summary
Rheumatic heart disease, a consequence of acute rheumatic fever, is a disease of poverty. Despite a dramatic reduction of RHD in Australia overall, it continues to be a major contributor to childhood and adult cardiac disease in Indigenous communities. These studies seek to enhance the detection of patients with suspected ARF and improve the prediction of the development of future RHD. We will demonstrate changes in heart muscle and valve structure and function using non-invasive testing.
Enhancing The Prevention, Diagnosis And Management Of Acute Rheumatic Fever And Rheumatic Heart Disease In Aboriginal Australian And Torres Strait Islander Populations
Funder
National Health and Medical Research Council
Funding Amount
$73,688.00
Summary
I am a health researcher focused on improving the diagnosis and care of rheumatic heart disease (RHD) in Indigenous Australians. I am examining the use of heart ultrasounds to detect the earliest stages of RHD in Indigenous children. Earlier detection can lead to earlier treatment and therefore less heart damage. I also intend to improve care for people with RHD by evaluating health services to determine what factors enhance outcomes for people with RHD.
A vaccine against the bacteria Group A streptococcus (‘strep’) could prevent common minor infections like sore throat and school sores as well as deadly ones like necrotising fasciitis (‘flesh eating disease’). It would also reduce long-term heart (rheumatic heart disease) and kidney problems. We are going to try and deliberately give a sore throat to adult volunteers under very close medical supervision so that we can learn more about immunity to strep and to help make and test new vaccines.
I am a paediatrician with experience in tropical medicine in northern Australia, the Solomon Islands and Fiji. The prevalence of Rheumatic Heart Disease in the Pacific, including Indigenous children in Australia, is amongst the highest in the world, and my project will investigate ways to reduce the burden of this disease. I will examine population screening with echocardiography (ultrasound) to detect the disease before children become sick, and investigate ways to improve patient management.
Evidence-based Policy To End Rheumatic Heart Disease In Australia
Funder
National Health and Medical Research Council
Funding Amount
$128,224.00
Summary
Rheumatic heart disease (RHD) occurs when untreated infections from streptococcal bacteria cause heart valve damage. RHD is almost exclusively a disease of Aboriginal and Torres Strait Islander Australians. Researchers are working on an endgame for RHD which will provide a set of recommendations to end the disease. This PhD is to understand how to ensure those recommendations are implemented. The outcomes will also help to control other diseases which are more common in Indigenous Australians.
Rheumatic Heart Disease (RHD) In Pregnancy: Challenges Of Health Service Provision
Funder
National Health and Medical Research Council
Funding Amount
$38,552.00
Summary
The burden of rheumatic heart disease (RHD) in pregnancy can be significant and in Australia is mostly confined to Aboriginal and Torres Strait Islander women. This study explores the barriers to timely diagnosis and best practice care for pregnant women with RHD, through 1) a study of reporting and health information systems related to RHD in pregnancy; and 2) an examination of health professionals’ knowledge, experiences of and attitudes to provision of care for pregnant women with RHD.
Rheumatic heart disease (RHD) is rare in developed countries except in indigenous populations where there is a shortage of quality health care, overcrowding, poverty and poor nutrition as in remote Australia. Advanced RHD affects the heart valves which can lead to heart failure, an increased risk of stroke and infection of the heart. The aim of this research project will be to inform the development of rational and evidence-based recommendations for the management of advanced RHD.
THE EFFECT OF LONG ACTING BRONCHODILATORS ON VENTILATION IN COPD
Funder
National Health and Medical Research Council
Funding Amount
$143,676.00
Summary
COPD is a common and important smoking-related lung disease. Well-established treatments with inhaled medications including long-acting bronchodilators have a proven clinical track record. However the physiological basis for their effects is still under investigation. This research examines some of the physiological changes in lung function and the response to long-acting bronchodilators in patients with COPD, and may help explain why some patients respond to therapy while others do not, leading ....COPD is a common and important smoking-related lung disease. Well-established treatments with inhaled medications including long-acting bronchodilators have a proven clinical track record. However the physiological basis for their effects is still under investigation. This research examines some of the physiological changes in lung function and the response to long-acting bronchodilators in patients with COPD, and may help explain why some patients respond to therapy while others do not, leading to more targeted therapeuticsRead moreRead less